Please try another search
Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company’s product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products. It also offers cardio cerebrovascular, blood pressure and sugar reduction, tonifying, qi-regulating, anti-anemia, antibacterial and anti-inflammatory, gastrointestinal tract, and expectorant cough category products. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold, fever, cardiovascular diseases, and anemia. In addition, the company offers business management and consulting services; and engages in the sale of construction material and electricity. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Name | Age | Since | Title |
---|---|---|---|
Qingfen Meng | 56 | 2017 | Executive Director |
Taisheng Hou | 58 | 2017 | Executive Director |
Yongsheng Chi | 59 | 2017 | Executive Director |
Kit Wa To | 45 | 2020 | Independent Non-Executive Director |
Wing Chun Sze | 44 | 2018 | Independent Non-Executive Director |
Zhiming Cao | 35 | 2013 | CEO & Executive Director |
Kwok Tung Lee | 53 | 2019 | Independent Non-Executive Director |
Changcheng Cao | 64 | 2016 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review